In the US, Bepridil (bepridil systemic) is a member of the drug class calcium channel blocking agents and is used to treat Angina Pectoris Prophylaxis.
US matches:
- Bepridil
Scheme
Rec.INN
ATC (Anatomical Therapeutic Chemical Classification)
C08EA02
CAS registry number (Chemical Abstracts Service)
0064706-54-3
Chemical Formula
C24-H34-N2-O
Molecular Weight
366
Therapeutic Categories
Antiarrhythmic agent
Calcium channel blocker
Chemical Name
1-Pyrrolidineethanamine, ß-[(2-methylpropoxy)methyl]-N-phenyl-N-(phenylmethyl)-
Foreign Names
- Bepridilum (Latin)
- Bepridil (German)
- Bépridil (French)
- Bepridil (Spanish)
Generic Names
- Bepridil (OS: BAN)
- Bépridil (OS: DCF)
- CERM 1978 (IS)
- Bepridil Hydrochloride (OS: BANM, USAN)
- Org 5730 (IS: Organon)
Brand Names
- Bepricor
Schering-Plough, Japan - Kaike
Changzhou Siyao, China - Unicordium
Organon, France
International Drug Name Search
Glossary
BAN | British Approved Name |
BANM | British Approved Name (Modified) |
DCF | Dénomination Commune Française |
IS | Inofficial Synonym |
OS | Official Synonym |
Rec.INN | Recommended International Nonproprietary Name (World Health Organization) |
USAN | United States Adopted Name |
Click for further information on drug naming conventions and International Nonproprietary Names.
No comments:
Post a Comment